Jiang Song, Liu Mao-Sheng, Wang Ting, Zhang Kun-He
Department of Gastroenterology, Jiangxi Institute of Gastroenterology & Hepatology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Curr Med Chem. 2024 Feb 14. doi: 10.2174/0109298673280993240125091756.
OBJECTIVE: Aptamers are increasingly applied in cancer research. Here, we have performed the first bibliometric analysis to demonstrate the evolution of aptamers in cancer research over the past decade and to reveal future trends. METHOD: Original articles and reviews on aptamers in cancer research published from 2013 to 2022 were retrieved from the Web of Science Core Collection database. VOSviewer, CiteSpace, and R software were used for bibliometric analysis of the literature and visualization of the results. RESULTS: A total of 1627 eligible publications were analyzed. Annual and cumulative publications have been found to be steadily increased. China was the most productive country (884 publications) and Hunan University was the most productive institution (97 publications). The United States had the highest level of international collaboration (betweenness centrality = 0.55). Wei-Hong Tan was the most productive author (68 publications) and Craig Tuerk was the most cited author (387 citations). Analytical Chemistry and Biosensors and Bioelectronics were the most influential journals in this field. Three major themes were identified: aptamer selection techniques, aptamer-targeted drug delivery, and aptasensors for cancer detection. The research hotspots have shifted from aptamer selection, targeted drug delivery, molecular imaging, and biomarker detection to electrochemical aptasensors and therapeutic applications. The future may focus on high specificity and affinity in aptamer selection, aptasensor fabrication, aptamer- targeted drug delivery, and therapeutic aptamer development. CONCLUSION: The field of aptamers in cancer research has been steadily developing over the past decade, and future research may focus on aptamer application in cancer detection and therapy and the improvement of aptamer selection.
目的:适体在癌症研究中的应用日益广泛。在此,我们进行了首次文献计量分析,以展示过去十年适体在癌症研究中的发展历程,并揭示未来趋势。 方法:从科学网核心合集数据库中检索2013年至2022年发表的关于适体在癌症研究中的原创文章和综述。使用VOSviewer、CiteSpace和R软件对文献进行文献计量分析并将结果可视化。 结果:共分析了1627篇符合条件的出版物。发现年度和累计出版物数量稳步增加。中国是产出最多的国家(884篇出版物),湖南大学是产出最多的机构(97篇出版物)。美国的国际合作水平最高(中间中心性 = 0.55)。谭蔚泓是产出最多的作者(68篇出版物),克雷格·图尔克是被引次数最多的作者(387次引用)。《分析化学》以及《生物传感器与生物电子学》是该领域最具影响力的期刊。确定了三个主要主题:适体筛选技术、适体靶向药物递送以及用于癌症检测的适体传感器。研究热点已从适体筛选、靶向药物递送、分子成像和生物标志物检测转向电化学适体传感器和治疗应用。未来可能会聚焦于适体筛选、适体传感器制造、适体靶向药物递送和治疗性适体开发中的高特异性和高亲和力。 结论:在过去十年中,适体在癌症研究领域一直在稳步发展,未来的研究可能会聚焦于适体在癌症检测和治疗中的应用以及适体筛选的改进。
Front Oncol. 2025-6-30
J Assist Reprod Genet. 2025-2
Quant Imaging Med Surg. 2025-7-1
J Biol Eng. 2025-2-7
Small Methods. 2023-6
Biosensors (Basel). 2023-3-18
Int J Biol Macromol. 2023-5-31
Cancer Cell. 2023-3-13
Technol Cancer Res Treat. 2022
Cancers (Basel). 2022-12-30
J Med Libr Assoc. 2022-7-1